BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
2.230
-0.060 (-2.62%)
Jul 3, 2025, 1:00 PM - Market closed
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $89.91 million as of July 3, 2025. Its market cap has decreased by -17.74% in one year.
Market Cap
89.91M
Enterprise Value
81.93M
1-Year Change
-17.74%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $89.91M, a decrease of -75.17%. That is a compound annual growth rate of -15.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 89.90M | 36.83% |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |